Watchlist Price Alert

DiaMedica Therapeutics In... (DMAC)

NASDAQ: DMAC · Real-Time Price · USD

3.82

-0.13 (-3.29%)

At close: Jun 26, 2025, 3:59 PM

4.00

4.71%

Pre-market: Jun 27, 2025, 08:00 AM EDT

DiaMedica Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.02M	4.54M	4.73M	4.71M	7.41M	3.88M	16.82M	1.35M	1.74M
Short-Term Investments	41.12M	48.35M	28.77M	40.41M	20.1M	4M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.31M	n/a	n/a	n/a	n/a	n/a	271K	271K	0.00
Receivables	236K	369K	82K	130K	340K	823K	780K	80K	51.97K
Inventory	n/a	n/a	n/a	113K	10K	88K	n/a	n/a	n/a
Other Current Assets	227K	n/a	n/a	n/a	64K	47K	n/a	n/a	n/a
Total Current Assets	44.61M	53.67M	33.84M	45.44M	27.92M	8.84M	17.97M	1.49M	1.85M
Property-Plant & Equipment	427K	485K	560K	112K	174K	217K	96K	37K	19.39K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.74M	485K	560K	112K	174K	217K	367K	308K	19.39K
Total Assets	46.34M	54.16M	34.4M	45.55M	28.09M	9.05M	18.34M	1.8M	1.87M
Account Payables	940K	926K	734K	509K	1.1M	182K	483K	513K	250K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	34K	n/a	-200.46K
Short-Term Debt	n/a	n/a	69K	49K	65K	60K	n/a	n/a	n/a
Other Current Liabilities	4.45M	766K	629K	435K	418K	597K	417K	439K	97.97K
Total Current Liabilities	5.39M	2.79M	2.17M	1.52M	2.03M	1.32M	1.3M	1M	626.97K
Long-Term Debt	237K	n/a	400K	3K	53K	118K	18K	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-400K	-3K	-53K	-118K	-18K	n/a	n/a
Total Long-Term Liabilities	237K	317K	400K	3K	53K	118K	18K	n/a	n/a
Total Liabilities	5.63M	3.1M	2.57M	1.53M	2.08M	1.44M	1.31M	1M	626.97K
Total Debt	340K	400K	469K	52K	118K	178K	23K	n/a	200.46K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	40.99M
Retained Earnings	-140M	-115.56M	-96.18M	-82.5M	-68.91M	-56.62M	-45.97M	-40.23M	-46.71M
Comprehensive Income	23K	6K	-74K	-51K	-2K	2K	-24K	610.88K	587.08K
Shareholders Equity	40.72M	51.06M	31.83M	44.02M	26.01M	7.62M	17.02M	799K	1.25M
Total Investments	41.12M	48.35M	28.77M	40.41M	20.1M	4M	n/a	n/a	n/a